Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: CHIESI FARMACEUTICI SpA, Via Palermo 26/A, 43122, Parma, ITALY
Peyona 20 mg/ml solution for infusion and oral solution.
| Pharmaceutical Form |
|---|
|
Solution for infusion. Oral solution. Clear, colourless, aqueous solution at pH=4.7. |
Each ml contains 20 mg caffeine citrate (equivalent to 10 mg caffeine).
Each 1 ml ampoule contains 20 mg caffeine citrate (equivalent to 10 mg caffeine)
Each 3 ml ampoule contains 60 mg caffeine citrate (equivalent to 30 mg caffeine).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Caffeine |
Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant. |
| List of Excipients |
|---|
|
Citric acid monohydrate |
Type I clear glass 1 ml ampoule.
Type I clear glass 3 ml ampoule.
Pack size of 10 ampoules.
CHIESI FARMACEUTICI SpA, Via Palermo 26/A, 43122, Parma, ITALY
EU/1/09/528/002 1ml ampoules
EU/1/09/528/001 3ml ampoules
Date of first authorisation: 02/07/2009
Date of latest renewal: 03/03/2014
| Drug | Countries | |
|---|---|---|
| PEYONA | Austria, Brazil, Canada, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
